Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sinomenine mitigates cisplatin-induced kidney injury by targeting multiple signaling pathways
Iva Potočnjak, Lidija Šimić, Lara Batičić, et al.
Food and Chemical Toxicology (2022) Vol. 171, pp. 113538-113538
Closed Access | Times Cited: 10

Showing 10 citing articles:

Bioactivities and Mechanisms of Action of Sinomenine and Its Derivatives: A Comprehensive Review
Wen Hou, Lejun Huang, Hao Huang, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 540-540
Open Access | Times Cited: 11
Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin—The Crucial Limitation or Potential Therapeutic Target?
Jelena Katanić, Dragica Selaković, Gvozden Rosić
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14574-14574
Open Access | Times Cited: 20
The interplay of mitophagy, autophagy, and apoptosis in cisplatin-induced kidney injury: involvement of ERK signaling pathway
Iva Suman, Lidija Šimić, Gordana Čanadi Jurešić, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Herkinorin ameliorates neuronal damage in a pentylenetetrazol-induced epilepsy rat model through altering microglial and astrocytic activation by inhibiting PARP1 and NF-κB
Yun Liu, Wenmei Zhao, Xia Lv, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114588-114588
Closed Access
Dihydromyricetin protects against cisplatin-induced renal injury and mitochondria-mediated apoptosis via the EGFR/HSP27/STAT3 signaling pathway
Zheming Xu, Minjing Zhang, Zhang Xue, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Isorhamnetin alleviates cisplatin-induced acute kidney injury via enhancing fatty acid oxidation
Lingkun Wang, Yaochen Xie, Boneng Xiao, et al.
Free Radical Biology and Medicine (2023) Vol. 212, pp. 22-33
Closed Access | Times Cited: 8
Amelioration of Cisplatin-Induced kidney injury by Arabinogalactan based on network pharmacology and molecular docking
Jian‐Qiang Wang, Xiangxiang Liu, Junjie Zhang, et al.
Journal of Functional Foods (2023) Vol. 104, pp. 105504-105504
Open Access | Times Cited: 3
VALD‐2 mitigates cisplatin‐induced acute kidney injury: Mechanistic insights into oxidative stress modulation and inflammation suppression
Xuhui Zhao, Yuna Meng, Chunyan Dang, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 8
Closed Access
Improved bioavailability of polydatin and its protective effect against cisplatin induced nephrotoxicity through self-assembled fucoidan and carboxymethyl chitosan delivery system
Yinghan Wang, Pengyu Xue, Liang Gao, et al.
International Journal of Biological Macromolecules (2024) Vol. 287, pp. 138577-138577
Closed Access
Shensu IV maintains the integrity of the glomerular filtration barrier and exerts renal protective effects by regulating endogenous hydrogen sulfide levels
Shuhui Zhou, Liping Zheng, Tiantian Zheng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top